EP2460520
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.10.2007EP published:
30.9.2015EP application number:
12152282.5
EPO information:
European Patent Register
Max expiry date:
10.10.2027
Title:
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
Timeline
Today
11.10.2007EP application
30.9.2015EP Publication
Owner
Name:
PTC Therapeutics, Inc.Address:
100 Corporate Court, Middlesex Business Center, 07080, South Plainfield, NJ, US
Inventor
Name:
Hirawat, SamitAddress:
Chatham, New Jersey, US
Name:
Miller, LangdonAddress:
Seattle, Washington, US
Priority
Number:
851450 PDate:
12.10.2006Country:
US
Classification
Categories:
A61K 31/4245, A61P 3/10, A61P 7/00, A61P 9/00